City

Beijing (1)

Bethesda (1)

Clovis (1)

Overall Status

Not yet recruiting (2)

Completed (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

phase 1 (1)

Sponsor

Beijing Tongren Hospital (2)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

University of California, San Francisco (1)

Collaborator

Intervention

placebo (2)

il-4r (1)

interleukin-4 receptor responders 1 (1)

interleukin-4 receptor responders 2 (1)

montelukast 10 mg oral tablet (1)

vrc-hivmab060-00-ab (1)

Study Documents

Intervention Type

biological (2)

drug (1)

other (1)

Funder Type

Other (3)

NIH (1)

Study Type

Interventional (3)

Observational (1)

monoclonal antibody

Showing 1 - 4 of 4

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Interleukin-4 Receptor, Monoclonal Antibody Trial (Interleukin-4 receptor responders 1, Interleukin-4 receptor responders 2,

Not yet recruiting

Interleukin-4 Receptor
Monoclonal Antibody

Interleukin-4 receptor responders 1
+2 more

(no location specified)

Jul 20, 2022

IL-4R Monoclonal Antibody for Chronic Rhino-sinusitis With

Not yet recruiting

Chronic Rhino-sinusitis
+3 more

IL-4R
Placebo

Beijing, Beijing, China

Beijing Tongren Hospital, Capital Medical University

Jun 17, 2022

Infusion Reaction, Monoclonal Antibody Trial in Clovis (Montelukast 10 Mg Oral Tablet)

Recruiting

Infusion Reaction
Monoclonal Antibody

Montelukast 10 Mg Oral Tablet

Clovis, California

Community Cancer Institute

Nov 8, 2021

HIV-1 Infection, Neutralizing Antibody, Monoclonal Antibody Trial run by the NIAID (VRC-HIVMAB060-00-AB)

Completed

HIV-1 Infection
+4 more

VRC-HIVMAB060-00-AB

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Dec 14, 2019